GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Biomaxima (WAR:BMX) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 18, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Biomaxima's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Biomaxima's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Biomaxima's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Biomaxima's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Biomaxima  (WAR:BMX) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Biomaxima Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Biomaxima's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomaxima Business Description

Industry
Traded in Other Exchanges
N/A
Address
5 Vetterow Street, Lublin, POL, 20-277
BioMaxima SA is a Polish company operating in the market of laboratory diagnostics. It is a manufacturer of microbiological substrates as well as a wide range of reagents and diagnostic equipment. The company is also a distributor of products of recognized multinational diagnostic companies such as: Accelerate Diagnostics, Nova Biomedical, PHC Group, Technoclone, Kabe and Biolog.

Biomaxima Headlines

No Headlines